Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02958462 · ClinicalTrials.gov registry record · NA
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
A NA study of Hematopoietic and Lymphatic System Neoplasm and Hematologic Neoplasms, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
- 3
- Study locations
NCT02958462: Recruiting NA study of Hematopoietic and Lymphatic System Neoplasm and Hematologic Neoplasms, sponsored by Mayo Clinic.
NCT02958462 is a NA study of Hematopoietic and Lymphatic System Neoplasm and Hematologic Neoplasms that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 2,000 participants, above the 451-participant average among 62 other Hematopoietic and Lymphatic System Neoplasm trials with a reported enrollment target (343% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02958462, a NA study of Hematopoietic and Lymphatic System Neoplasm and Hematologic Neoplasms, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial tests next generation sequencing (NGS) for the detection of precursor features of pre-myeloid cancers and bone marrow failure syndromes. NGS is a procedure that looks at relevant cancer associated genes and what they do. Finding genetic markers for pre-malignant conditions may help identify patients who are at risk of pre-myeloid cancers and bone marrow failure syndromes and lead to earlier intervention.
Primary Outcome
Assessed by the number of subjects whose cytopenias are persistent or progressive over the course of the study
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- PROCEDURE Bone Marrow Biopsy
- PROCEDURE Buccal Swab
- OTHER Clinical Evaluation
- PROCEDURE Punch Biopsy
Study Locations (3)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Florida
- Mayo Clinic in Florida - Jacksonville
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2017-01-16 |
| Est. Completion | 2035-09-15 |
| Phase | NA |
What NCT02958462 shows while recruiting
NCT02958462 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 451-participant average among 62 other Hematopoietic and Lymphatic System Neoplasm trials with a reported enrollment target (343% higher).
The record links to 10 conditions, with Hematopoietic and Lymphatic System Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT02958462 reports a single indexed study location in Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT02958462 about?
NCT02958462 is a clinical study titled "Pre-myeloid Cancer and Bone Marrow Failure Clinic Study". This clinical trial tests next generation sequencing (NGS) for the detection of precursor features of pre-myeloid cancers and bone marrow failure syndromes. NGS is a procedure that looks at relevant cancer associated genes and what they do. Finding genetic markers for pre-malignant conditions may he...
What is the current status of trial NCT02958462?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2017-01-16. Estimated completion is 2035-09-15.
What conditions does trial NCT02958462 study?
This clinical trial studies the following conditions: Hematopoietic and Lymphatic System Neoplasm, Hematologic Neoplasms, Cytopenia, Clonal Cytopenia of Undetermined Significance, Myeloid Malignancy.
What interventions are being tested in trial NCT02958462?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Bone Marrow Biopsy (PROCEDURE), Buccal Swab (PROCEDURE), Clinical Evaluation (OTHER), Punch Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02958462?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02958462 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic and Lymphatic System Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02958462's enrollment target sits among peer trials
2,000 4th of 62 higher than 58 of 62 other Hematopoietic and Lymphatic System Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hematopoietic and Lymphatic System Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
RECRUITING · NA
-
Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy
RECRUITING · NA
-
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting
RECRUITING · NA
-
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
RECRUITING · NA
-
Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With Cancer
RECRUITING · NA
-
A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI